ID Screen® SARS-CoV-2-N IgG Indirect ELISA

A highly reliable serology test to detect IgG antibodies against SARS-CoV-2.

Indirect semi-quantitative ELISA for the specific detection of IgG antibodies against the nucleocapsid of SARS-CoV-2 in human serum and plasma.


  • Approved by French authorities further to its evaluation by the French National Reference Centre
  • High sensitivity and specificity (99.9%) ensures accurate results, with clear discrimination of positive and negative samples
  • Excellent specificity and high positive predictive value, even in low prevalence areas, means a positive result reliably indicates if a person has been exposed to the virus and if the patient has developed antibodies

Rapid and easy-to-use:

  • Use manually or with any open automated immunoassay platform
  • Ready-to-use reagents
  • Results in 95 minutes
  • Possibility to operate on inactivated serum/plasma samples to guarantee operator’s safety

This product is CE marked and available for immediate shipping.

Our diagnostic tests are to be performed in laboratories by skilled technicians. They are distributed to laboratories only and are not available to private individuals.
If you are a private individual seeking a COVID-19 test, please consult healthcare professionals.


Method Semi-quantitative indirect ELISA
Species Humans
Specimens Serum or plasma
Coated antigen Purified recombinant antigen
Conjugate Protein G-HRP conjugate (concentrated 10X)

Ordering information

Product code Reactions Kit format Plate format
SARSCOV2S-4P 384 4 plates 12 x 8-well strips
SARSCOV2S-8P 768 8 plates 12 x 8-well strips